Globus Medical Reports Second Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Northland Capital Markets Upgrades Globus Medical (GMED) to Outperform
August 6, 2020 7:48 AM EDTNorthland Capital Markets analyst Jason Wittes upgraded Globus Medical (NYSE: GMED) from Market Perform to Outperform with a price target of $65.00.
The analyst commented, "2Q revs of $148.9mm (-23.4%) and EPS of $0.07, easily bested consensus of $99.7mm and ($0.11). Not a complete surprise,... More
Globus Medical (GMED) Tops Q2 EPS by 18c
August 5, 2020 5:13 PM EDTGlobus Medical (NYSE: GMED) reported Q2 EPS of $0.07, $0.18 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $148.9 million versus the consensus estimate of $99.73 million.
The Globus Team performed extremely well in the second quarter, said Dave Demski, President and CEO. Our worldwide revenue was down 23% in the quarter, an exceptional result when compared to our... More
